Skip to content

Milk Basic Protein

  • Plant preparation
  • Varies by country
  • Identity checked
  • Sources last checked 2026-09-04

This page shows what was measured, who it was measured in, and what that does not settle.

What Milk Basic Protein does in the body

Taken after training to build muscle, and generally to hit a daily protein target

Whey is the watery part of milk left behind when cheese is made, dried into a powder. It is digested unusually fast and is unusually rich in leucine, an amino acid that acts as a switch: when enough of it arrives in the blood at once, a sensor inside the muscle cell turns on the machinery that builds new protein. That switch stays on for a few hours and then turns off regardless of how much more protein you eat, which is why a very large dose is not proportionally better than a moderate one — the surplus is simply burned for energy.

What happened in people

Protein supplementation added 0.30 kg fat-free mass and 2.49 kg one-repetition maximum across 49 trials in 1,863 people

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

The recorded finding that sits closest to something a person would notice. Written into the record, not signed off, and it carries no population or interval.

The limit that matters most

That protein must be taken in a window around training, which vanished when total daily intake was controlled for

Where it acts
Skeletal muscle fibre cytoplasm, at the lysosomal surface where mTORC1 is activated; digestion and absorption in the proximal small intestine
Kind of result
Measured performance
Supervision
Not usually supervised: sold as a supplement or food ingredient where recorded. That is a legal category, not a safety judgement.

What the registries record it as

  • The substance registry classes this as structurallydiverse.

    FDA substance registry · 8617Z5FMF6 · read 2026-08-29

  • It is recorded as coming from BOS TAURUS WHOLE. The part recorded is milk.

    FDA substance registry · 8617Z5FMF6 · read 2026-08-29

  • The supplement label database classes it as protein, under the name Whey Protein.

    NIH Dietary Supplement Label Database · 1690 · read 2026-08-29

Where each sentence above came from

No recorded sentence describes the change this makes in a way that stands on its own. The page opens with what it is taken for instead, and the recorded explanation follows below.

Shown as the opening line on this page.

A limit recorded against this substance. Not signed off as a reviewed claim.

The four opening statements run to 139 words.

Words this page uses

Four words worth knowing first

Chosen from what this page shows, with each one explained before the word it depends on.

Stand-in result

A stand-in result is a number measured because the real result takes too long.

A picture of it, and where the picture fails

It is like judging a journey by the speedometer rather than by arriving.

Where that stops being true. Speed does predict arrival. Many stand-in results do not predict the real one.

What people get wrong. A stand-in result is often reported as the result itself.

A surrogate endpoint substituted for a clinical endpoint, valid only where the substitution has been shown to hold.

Randomisation

Randomisation means chance decides who gets which treatment.

A picture of it, and where the picture fails

It is like a coin toss deciding the groups.

Where that stops being true. A coin toss is fair once. Fairness here comes from doing it for everyone.

What people get wrong. It is thought to make groups identical. It makes them similar on average, including on things nobody measured.

Allocation of participants to arms by a chance process, so that unmeasured factors are balanced in expectation.

Absolute difference

An absolute difference is how many more people in a hundred were affected.

A picture of it, and where the picture fails

It is like counting heads in two rooms of a hundred.

Where that stops being true. Heads are easy to count. Study results carry a margin of error too.

What people get wrong. It is confused with a percentage change, which can look far larger.

The arithmetic difference in event rates between arms.

Confidence interval

A confidence interval is the range the true answer is likely to sit in.

A picture of it, and where the picture fails

It is like a weather forecast giving a range rather than one number.

Where that stops being true. A forecast range covers tomorrow. This one covers what the study could resolve.

What people get wrong. The middle number is read as the answer. A range crossing zero means no change is still possible.

An interval estimate that would contain the true parameter in a stated proportion of repeated studies.

What happened in peopleRead from sources, not yet reviewed

What was measured, goal by goal

One row for each goal a registered study measured something for. One column for each kind of thing that could be measured.

Registered studies list 40 outcome measures that RNAWiki could read. A registered study says what someone planned to measure. It does not say what they found. 0 of the matched studies tested this substance, and 0 posted a result.

There is no single score. A strong test result and a weak life result are different facts.

Goals down the side, kinds of measurement across the top. Each cell says what kind of thing was registered, not what was found.
GoalLife outcomeWhat a body can doHow a person feelsA test resultA step in the bodyHarmsHow longWho was studied
Body weightNothing in the sources checkedNo registered study lists a life outcome for this goal.Nothing in the sources checkedNo registered study lists a performance measure for this goal.Nothing in the sources checkedNo registered study lists a symptom measure for this goal.Only a number moved4 registered test measure.Nothing in the sources checkedNo registered study lists a body-step measure for this goal.Not recordedHarms were not a registered measure for this goal.Not recordedNo finished study window is recorded.Waiting for a reviewerWho was studied is listed further down the page.
StrengthNothing in the sources checkedNo registered study lists a life outcome for this goal.Waiting for a reviewer3 registered performance measure of this kind.Nothing in the sources checkedNo registered study lists a symptom measure for this goal.Nothing in the sources checkedNo registered study lists a test result for this goal.Nothing in the sources checkedNo registered study lists a body-step measure for this goal.Not recordedHarms were not a registered measure for this goal.Not recordedNo finished study window is recorded.Waiting for a reviewerWho was studied is listed further down the page.
MuscleNothing in the sources checkedNo registered study lists a life outcome for this goal.Nothing in the sources checkedNo registered study lists a performance measure for this goal.Nothing in the sources checkedNo registered study lists a symptom measure for this goal.Only a number moved3 registered test measure.Nothing in the sources checkedNo registered study lists a body-step measure for this goal.Not recordedHarms were not a registered measure for this goal.Not recordedNo finished study window is recorded.Waiting for a reviewerWho was studied is listed further down the page.
CholesterolNothing in the sources checkedNo registered study lists a life outcome for this goal.Nothing in the sources checkedNo registered study lists a performance measure for this goal.Nothing in the sources checkedNo registered study lists a symptom measure for this goal.Only a number moved2 registered test measure.Nothing in the sources checkedNo registered study lists a body-step measure for this goal.Not recordedHarms were not a registered measure for this goal.Not recordedNo finished study window is recorded.Waiting for a reviewerWho was studied is listed further down the page.
Blood sugarNothing in the sources checkedNo registered study lists a life outcome for this goal.Nothing in the sources checkedNo registered study lists a performance measure for this goal.Nothing in the sources checkedNo registered study lists a symptom measure for this goal.Only a number moved2 registered test measure.Nothing in the sources checkedNo registered study lists a body-step measure for this goal.Not recordedHarms were not a registered measure for this goal.Not recordedNo finished study window is recorded.Waiting for a reviewerWho was studied is listed further down the page.
EnduranceNothing in the sources checkedNo registered study lists a life outcome for this goal.Waiting for a reviewer2 registered performance measure of this kind.Nothing in the sources checkedNo registered study lists a symptom measure for this goal.Nothing in the sources checkedNo registered study lists a test result for this goal.Nothing in the sources checkedNo registered study lists a body-step measure for this goal.Not recordedHarms were not a registered measure for this goal.Not recordedNo finished study window is recorded.Waiting for a reviewerWho was studied is listed further down the page.
EnergyNothing in the sources checkedNo registered study lists a life outcome for this goal.Nothing in the sources checkedNo registered study lists a performance measure for this goal.Nothing in the sources checkedNo registered study lists a symptom measure for this goal.Nothing in the sources checkedNo registered study lists a test result for this goal.Nothing in the sources checkedNo registered study lists a body-step measure for this goal.Not recordedHarms were not a registered measure for this goal.Not recordedNo finished study window is recorded.Waiting for a reviewerWho was studied is listed further down the page.
SleepNothing in the sources checkedNo registered study lists a life outcome for this goal.Nothing in the sources checkedNo registered study lists a performance measure for this goal.Waiting for a reviewer1 registered symptom measure.Nothing in the sources checkedNo registered study lists a test result for this goal.Nothing in the sources checkedNo registered study lists a body-step measure for this goal.Not recordedHarms were not a registered measure for this goal.Not recordedNo finished study window is recorded.Waiting for a reviewerWho was studied is listed further down the page.
Which registered measures put each goal on this table
Body weight
body composition; lean body mass /fat mass; body mass index; changes in body composition
Strength
strength; muscular strength; isokinetic strength of lower limbs
Muscle
muscle mass; lean mass; lean body mass /fat mass
Cholesterol
triglyceride levels; postprandial triglyceride response
Blood sugar
plasma glucose; blood glucose level
Endurance
walk distance; heart rate during the speed endurance production training
Energy
lunch energy intake
Sleep
sleep quality

Sorted by fixed word lists, version v1. A name the rules do not recognise stays unsorted rather than moving to the nearest column.

What each mark on this table means
Nothing in the sources checked
No registered study lists a life outcome for this goal.
Only a number moved
4 registered test measure.
Not recorded
Harms were not a registered measure for this goal.
Waiting for a reviewer
Who was studied is listed further down the page.

What happened in peopleRead from sources, not yet reviewed

What happened in people

Each card is one study: the exact question it asked, who was in it, and whether it showed what it set out to show.

Change in fat-free mass and one-repetition-maximum strength

The study showed what it set out to show

Who was studied
Morton 2018 meta-analysis of protein supplementation and resistance training
How many people
1863
Study design
Meta-analysis and meta-regression of 49 randomised controlled trials
Compared against
Not recorded for this study
Kind of result
Measured performance
What was found
FFM +0.30 kg (95% CI 0.09 to 0.52); 1RM +2.49 kg (95% CI 0.64 to 4.33); break point at 1.62 g/kg/day total protein, beyond which no further FFM gain
Repeated elsewhere
Replicated

What this does not prove. Meeting one endpoint in one population does not carry to other goals or other people.

The limits of this study, and where it came from

Main limit. Effect on fat-free mass declined with age (-0.01 kg per year, P = 0.002) and was larger in already-trained individuals (+0.75 kg, P = 0.03) — the reverse of the pattern implied by marketing aimed at beginners and older adults.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral powder reconstituted in liquid; concentrate, isolate or hydrolysate

Interval reported. 95% CI 0

Written into the record, not signed off as a reviewed claim.

Fractional rate of mixed muscle protein synthesis at rest and after resistance exercise

The study showed what it set out to show

Who was studied
Tang 2009 — whey hydrolysate versus micellar casein versus soy isolate
How many people
18
Study design
Randomised parallel-group stable-isotope infusion study
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
After exercise, whey approximately 122% greater than casein (P < 0.01) and 31% greater than soy (P < 0.05); at rest 93% greater than casein (P < 0.01) and 18% greater than soy (P = 0.067)
Repeated elsewhere
Replicated

What this does not prove. Meeting one endpoint in one population does not carry to other goals or other people.

The limits of this study, and where it came from

Main limit. Six men per group and a single acute measurement. The resting whey-versus-soy comparison did not reach significance. Acute synthesis rates and long-term hypertrophy diverge often enough that this cannot be read as a training result.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral powder reconstituted in liquid; concentrate, isolate or hydrolysate

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

Muscle and albumin protein synthesis across 0, 5, 10, 20 and 40 g protein doses

The study showed what it set out to show

Who was studied
Moore 2009 — ingested protein dose response after resistance exercise
How many people
6
Study design
Randomised within-subject dose-response with stable-isotope infusion
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Maximal stimulation of muscle and albumin protein synthesis at 20 g; leucine oxidation significantly increased at 20 and 40 g
Repeated elsewhere
Partially Replicated

What this does not prove. Meeting one endpoint in one population does not carry to other goals or other people.

The limits of this study, and where it came from

Main limit. Six young men, whole egg protein, single-limb exercise. The 20 g plateau is widely generalised to older adults and whole-body training, where the evidence suggests a higher threshold.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral powder reconstituted in liquid; concentrate, isolate or hydrolysate

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

Muscle strength and hypertrophy effect size attributable to protein timing

The study did not show it

Who was studied
Schoenfeld 2013 meta-regression of protein timing
How many people
525
Study design
Multi-level meta-regression of randomised controlled trials
Compared against
Not recorded for this study
Kind of result
Measured performance
What was found
Simple pooled analysis showed a small-to-moderate hypertrophy effect; in the full model controlling for covariates, no significant difference for strength or hypertrophy
Repeated elsewhere
Replicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. Total protein intake was the strongest predictor of hypertrophy effect size, meaning the apparent timing effect was a total-intake effect in disguise.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral powder reconstituted in liquid; concentrate, isolate or hydrolysate

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

Glomerular filtration rate on higher versus normal or lower protein intake

The study did not show it

Who was studied
Devries 2018 meta-analysis of higher-protein intake and kidney function
How many people
1358
Study design
Systematic review and meta-analysis of 28 randomised controlled trials
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Post-intervention GFR SMD 0.19 (95% CI 0.07 to 0.31), P = 0.002; change in GFR SMD 0.11 (95% CI -0.05 to 0.27), P = 0.16
Repeated elsewhere
Replicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. Restricted to adults without kidney disease, and trials were short relative to habitual lifetime intake. Post-intervention GFR was higher on high protein, which is read as adaptive hyperfiltration rather than injury — a reading, not a measurement.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral powder reconstituted in liquid; concentrate, isolate or hydrolysate

Interval reported. 95% CI 0

Written into the record, not signed off as a reviewed claim.

What we know
RNAWiki holds 5 written-up human studies for this substance, each with the question it asked.
How we know it
Each card names the study, the number of people and what the study set out to measure.
What this does not prove
These summaries were written by a person and have not been signed off as reviewed claims.
Why it matters
A study that failed is as informative as one that worked, and both are here.
What we still do not know
No reviewed claim exists, so no exact population, effect size or interval is published yet.

What happened in peopleRead from sources, not yet reviewed

How close this is to real life

The top step is something a person would feel or care about. The bottom is a guess from software. Filled steps are where evidence exists for this substance.

  1. Living longer, or avoiding a major event No evidence recorded. Death, a heart attack, a stroke, a hospital stay.No registered study measures this.
  2. What a body can do day to day Evidence recorded. Walking, dressing, breathing, recovering.9 registered measures of this kind.
  3. Measured performance Evidence recorded. How much was lifted, how far was run, how fast.9 registered measures of this kind.
  4. Symptoms and quality of life Evidence recorded. Pain, tiredness, mood, sleep, as the person rated it.3 registered measures of this kind.
  5. A number that stands in for health Evidence recorded. Cholesterol, blood sugar, bone density. A stand-in, not the thing itself.13 registered measures of this kind.
  6. A step measured inside a person Evidence recorded. Something measured in human tissue or human cells.A human record sits on the stored organism ladder.
  7. Animals No evidence recorded. Mice, rats, dogs. Useful for ideas, not proof about people.No animal record is stored.
  8. Cells in a dish No evidence recorded. Cells or chemistry on a bench, far from a whole body.No cell or bench record is stored.
  9. A guess from software No evidence recorded. Nobody measured it. RNAWiki never publishes one as a finding.RNAWiki stores no prediction for this record. Software can suggest a link. RNAWiki does not publish one as a finding.

Higher on these steps means closer to something a person would feel. It does not mean better done.

What it changes in the bodyRead from sources, not yet reviewed

The path through the body

From what a person takes to what changes. A solid line is a step measured in people. A dashed line is a step nobody has measured that way.

  1. Start

    Milk Basic Protein

    What a person takes: Oral powder reconstituted in liquid; concentrate, isolate or hydrolysate.

    The measurement behind this step

    Sold in the United States as a dietary supplement under DSHEA, so no agency reviewed efficacy, safety or content before sale. The three grades differ by processing rather than by biology: concentrate retains more lactose and fat, isolate is filtered further to a higher protein percentage, and hydrolysate is pre-cleaved into peptides for faster absorption. All three deliver the same amino acids, and leucine content per gram of protein is nearly identical between them. Label protein content is usually derived from total nitrogen, which is inflatable by nitrogen-rich non-protein additives, so a full amino acid profile is the only assay that verifies the claim.

  2. Getting in

    Digested fast, which is the whole point of whey

    Whey stays liquid in the stomach instead of clotting, so it empties quickly and floods the bloodstream with amino acids within about half an hour. Casein does the opposite.

    Measured in people. Written by a person from the study named beside the step. Not signed off as a reviewed claim.

    The measurement behind this step

    Whey proteins remain soluble at gastric pH while casein micelles precipitate into a curd, producing a much faster gastric emptying and a sharper plasma aminoacidaemia. Tang et al. measured the consequence: blood essential amino acid, branched-chain amino acid and leucine concentrations all rose more after whey than after casein or soy (P < 0.05). Hydrolysing whey further accelerates this without changing the amino acids delivered.

  3. Reaching the cell

    Leucine is the signal, not protein in general

    The muscle cell is not counting grams of protein. It is watching for one amino acid, and when enough of it arrives at once, a switch flips.

    Described, with no measurement named. No measurement is named for this step, so it is drawn as an unconfirmed link.

    The measurement behind this step

    Leucine binds Sestrin2, releasing its inhibition of GATOR2, which permits mTORC1 activation at the lysosomal surface. Whey is roughly 10 to 11 percent leucine by weight, higher than casein and considerably higher than most plant proteins, which is the single best explanation for the whey-over-soy-over-casein ordering in acute synthesis measurements.

  4. What it acts on

    mTORC1 switches on the protein-building machinery

    Once triggered, a master kinase turns on the cellular machinery that reads genetic instructions into new muscle protein. It stays on for a few hours.

    Described, with no measurement named. No measurement is named for this step, so it is drawn as an unconfirmed link.

    The measurement behind this step

    Activated mTORC1 phosphorylates p70S6K and 4E-BP1, relieving translational repression and increasing translation initiation. Notably, Moore et al. found phosphorylation of p70S6K Thr389, ribosomal protein S6 Ser240/244 and eIF2B-epsilon Ser539 was unaffected across protein doses from 0 to 40 g, which argues the dose-response in synthesis is driven by substrate availability rather than by graded signalling.

  5. The change it makes

    The response saturates, and the surplus is burned

    Past about twenty grams the building rate stops rising. Extra protein does not sit around waiting; it gets oxidised for energy.

    Described, with no measurement named. No measurement is named for this step, so it is drawn as an unconfirmed link.

    The measurement behind this step

    Moore et al. found muscle protein synthesis and albumin synthesis both maximally stimulated at 20 g of whole egg protein after resistance exercise, with whole-body leucine oxidation rising significantly at 20 and 40 g. The plateau is a property of the anabolic response, not of absorption — the amino acids are absorbed either way, they are simply deaminated and the carbon skeletons oxidised.

  6. What that does for a person

    Over months this compounds into about a third of a kilogram

    Repeated across a training block, the extra synthesis adds up to a small but genuine amount of additional muscle over training alone.

    Measured in people. Written by a person from the study named beside the step. Not signed off as a reviewed claim.

    The measurement behind this step

    Across 49 randomised trials and 1,863 participants, protein supplementation added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52), 2.49 kg of one-repetition maximum (95% CI 0.64 to 4.33) and 310 square micrometres of muscle fibre cross-sectional area (95% CI 51 to 570) beyond training alone — with the whole effect conditional on total protein intake being below 1.62 g/kg/day.

No suggested links are held for this record, so nothing is hidden from this path.

What we know
The record describes 5 steps from taking it to an effect in a person.
How we know it
Each step names the study behind it in the technical detail beside it.
What this does not prove
A change inside the body is a reason to look. It is not a result in a person.
Why it matters
A reader can see exactly where the chain stops being measured in people.
What we still do not know
No reviewed claim binds any of these steps to a named population.

What it would be like to takeRead from sources, not yet reviewed

Felt, measured, or meaningful

Three different things that get called the same word. Registered studies measured all three, and mixing them is how a blood test becomes a health claim.

Felt

Things a person could notice without a test.

  • post prandial satiety
  • perceived hunger
  • sleep quality

Measured

Things only a test, a scale or a device shows.

  • systolic and diastolic blood pressure
  • triglyceride levels
  • postprandial triglyceride response
  • body composition
  • strength
  • plasma glucose
  • muscle mass
  • lean mass
  • lean body mass /fat mass
  • blood glucose level

and 9 more.

Meaningful

Things that change how a life goes, not only a number.

  • six minute walk test
  • 4 meter gait speed
  • walk distance

A registered study says what someone planned to measure. It does not say what they found. A number moving is not the same as a life going better. The two are shown apart here.

Felt, but not shown to help. A person notices a change. No study showed it leads anywhere good.

Measured, but not felt. A number moves. The person notices nothing. Both can be true.

Measured, but not shown to matter. A number moves in the good direction. Nobody showed that lives went better.

Matters, but takes years. The result that counts may take longer than anyone would keep watching.

Names that fit none of the three (15)
  • net whole body protein balance
  • net whole body protein synthesis
  • muscle protein synthesis
  • metabolism
  • muscle function
  • visceral fat
  • nutritional status
  • physical performance
  • muscle phenylalanine netbalance over the forearm muscle
  • physical capacity through the maximum distance traveled
  • perceived fullness
  • perceived desire to eat
  • perceived prospective food consumption
  • lunch energy intake
  • maximal voluntary isometric contraction of lower limbs

These are harms, study-process measures, or names the rules did not recognise. They are shown rather than dropped.

What is missing or unclearRead from sources, not yet reviewed

Were people like you studied?

RNAWiki cannot tell whether a study fits you. It can show who was in it, and where the result stops carrying.

Who was studied

People similar to this profile were included.

  • Lifters and athletes, older adults being treated for sarcopenia, hospital patients on enteral nutrition, and a very large number of people who simply find a shake more convenient than cooking.

Who is missing from the studies

  • Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

Where the result stopped carrying

  • The anabolic window, refuted in a meta-regression of 43 study groups once total protein was entered as a covariate
  • The high-protein kidney warning, which did not survive 28 randomised trials in healthy adults
  • This is a scope explorer, not a diagnosis engine.
  • It shows who was studied so you can see whether people similar to you were included.

RNAWiki cannot tell whether a study fits you. It can show who was in it.

What it would be like to takeRead from sources, not yet reviewed

Why it might seem to do nothing

A real effect and a noticed effect are different things. These are the recorded reasons the two come apart.

It was studied for a different goal

The studies measured something else entirely.

On this record: Some registered studies measured things that match no goal on this page.

It was studied in different people

The people in the studies were not much like the reader.

On this record: Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

Something else had to happen too

In the studies it was paired with training, a diet or another treatment.

On this record: Repeated across a training block, the extra synthesis adds up to a small but genuine amount of additional muscle over training alone.

The evidence may simply be wrong

Small early studies often do not hold up.

On this record: RNAWiki has not yet published a reviewed conclusion for this use.

The product may not be what it says

Contents of a sold product are not always what the label states.

On this record: This is sold as a supplement, so no agency checked what is in a given tub before it was sold.

Other reasons RNAWiki checked and found nothing for (8)
A different form was studied
The studied form is not the form on the shelf. Nothing in this record points to this reason.
There was nothing to correct
Where a level is already normal, topping it up may change nothing. Nothing in this record points to this reason.
The change is too small to feel
A real change can still sit below what a person notices. Nothing in this record points to this reason.
Day-to-day swing hides it
Sleep, food, stress and time of day move most numbers more than this would. Nothing in this record points to this reason.
Not enough time yet
The studies ran longer than the person has waited. Nothing in this record points to this reason.
It was not taken as studied
Missed days change the result, and studies count them. Nothing in this record points to this reason.
Something else changed at the same time
Two changes at once cannot be told apart afterwards. Nothing in this record points to this reason.
No recorded reason
RNAWiki has nothing stored that would explain it. Nothing in this record points to this reason.

None of these is a reason to take more. Taking more is not a step this page ever suggests.

What it would be like to takeRead from sources, not yet reviewed

What taking it involves

The recorded facts about getting hold of it and using it. Nothing here is a suggestion about what you should do.

How it is supplied

Varies by country

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

Read from the recorded approval status.

No source is stored against this line.

Form and route

Oral powder reconstituted in liquid; concentrate, isolate or hydrolysate

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

The form and route recorded on this substance.

No source is stored against this line.

Who oversees it

Not usually supervised: sold as a supplement or food ingredient where recorded. That is a legal category, not a safety judgement.

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

The identity record classes it as a supplement ingredient; no medicines register records an approval.

No source is stored against this line.

What is in the pack

Sold in the United States as a dietary supplement under DSHEA, so no agency reviewed efficacy, safety or content before sale.

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

Recorded notes on how this is sold. The rest of the recorded wording: The three grades differ by processing rather than by biology: concentrate retains more lactose and fat, isolate is filtered further to a higher protein percentage, and hydrolysate is pre-cleaved into peptides for faster absorption. All three deliver the same amino acids, and leucine content per gram of protein is nearly identical between them. Label protein content is usually derived from total nitrogen, which is inflatable by nitrogen-rich non-protein additives, so a full amino acid profile is the only assay that verifies the claim.

No source is stored against this line.

Where it is registered

Regulatory records are listed in the technical disclosure at the foot of this page.

Counted from records

Where this came from

A count of rows RNAWiki holds. It describes our records, not your body.

Register entries are stored per jurisdiction and shown with their dates.

No source is stored against this line.

Why people stop

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

No record of why people stopped taking it is stored for this substance.

No source is stored against this line.

What it would be like to takeRead from sources, not yet reviewed

What can go wrong

Sorted by where each line came from. A regulator's label and a report somebody sent in are not the same kind of fact.

Worth asking a clinician aboutWritten into the record from the studies named on this page

Bloating, flatulence and diarrhoea in lactose-intolerant users of concentrate, which isolate largely avoids. Cow's milk protein allergy is a genuine contraindication and is not the same as lactose intolerance. Higher protein intake does not change glomerular filtration rate in healthy adults across 28 randomised trials, but that evidence does not extend to existing chronic kidney disease, where protein restriction remains standard. Independent testing has repeatedly found arsenic, cadmium, mercury and lead in this product category, with plant-based and mass-gain formulas worse than whey; a subsequent risk assessment by industry-adjacent consultants calculated hazard indices below the regulatory screening threshold.

Nobody counted how many people took this and were fine, so this cannot be turned into a rate.

Where this came from

Over a long time. No completed tested study window is recorded, so long-term effects are not established by the registry record.

Groups the studies covered thinly. Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What is missing or unclearNothing found in the sources checked

Does the exact form matter?

Evidence belongs to the exact thing that was tested. A different salt, a different mixture or a different preparation is a different question.

The form that was studied

Oral powder reconstituted in liquid; concentrate, isolate or hydrolysate

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

The form used in the studies cited on this page.

No source is stored against this line.

What is sold

A recorded note compares this form with the others that are sold. It is kept below, word for word.

A fixed RNAWiki sentence

Where this came from

Wording RNAWiki always uses, not a finding about this substance.

The recorded note, unchanged: The three grades differ by processing rather than by biology: concentrate retains more lactose and fat, isolate is filtered further to a higher protein percentage, and hydrolysate is pre-cleaved into peptides for faster absorption. All three deliver the same amino acids, and leucine content per gram of protein is nearly identical between them. Label protein content is usually derived from total nitrogen, which is inflatable by nitrogen-rich non-protein additives, so a full amino acid profile is the only assay that verifies the claim.

No source is stored against this line.

Evidence carries across two names for one substance. It does not carry across a salt, a mirror form or a mixture.

What it would be like to takeRead from sources, not yet reviewed

What you could measure

Watching one thing carefully can tell you whether it moved. It cannot tell you what moved it.

This is sold without a prescription, so a person can sensibly watch one thing and see whether it moves.

  1. Pick one goal. One goal only. Two at once cannot be told apart afterwards.

  2. Pick one thing to watch. Registered studies measured things like: systolic and diastolic blood pressure; triglyceride levels; postprandial triglyceride response.

  3. Measure before you start. Take the same measurement several times first. One reading is not a starting point.

  4. Know the swing. Write down how much it moves on its own across a normal week.

  5. Change one thing. Change nothing else at the same time, including training and sleep.

  6. Give it the study length. No finished study window is recorded, so no length is suggested here.

  7. Track whether you took it. Missed days are the most common reason a home test shows nothing.

  8. Read the trend. Look at the line across weeks. A single reading tells you almost nothing.

What not to measure

  • Anything that swings more day to day than the change you are looking for.
  • A wearable estimate of sleep stages, which is an estimate and not a measurement.
  • Weight on one morning, which mostly records water.
  • A feeling you did not write down before starting, such as: post prandial satiety.

When to stop

  • Stop if something new and unpleasant starts, and ask a pharmacist or doctor.
  • Stop if you cannot keep everything else steady, because the result will not mean anything.
  • Stop at the end of the window you set, and read the trend then.

Tracking can show whether something changed for you. It cannot show what caused it.

RNAWiki does not work out an amount for anyone.

What is missing or unclearRead from sources, not yet reviewed

Claims that go past the evidence

Things said about this substance that sound reasonable, and the exact step that is missing between the evidence and the claim.

Goes past the evidence

That protein must be taken in a window around training, which vanished when total daily intake was controlled for

Why it sounds right. It follows from something real on this page: a body step, an animal result or a related finding.

The missing step. Nobody measured this in people for this use, or the study that did measure it did not show it.

What would change this

A study in people, for this exact use, measuring this exact thing, that a reviewer signs off.

RNAWiki has not yet published a reviewed conclusion for this use.

Goes past the evidence

That a larger serving produces a proportionally larger response, when the response plateaued at 20 g

Why it sounds right. It follows from something real on this page: a body step, an animal result or a related finding.

The missing step. Nobody measured this in people for this use, or the study that did measure it did not show it.

What would change this

A study in people, for this exact use, measuring this exact thing, that a reviewer signs off.

RNAWiki has not yet published a reviewed conclusion for this use.

Goes past the evidence

That whey's acute superiority over casein and soy translates into superior long-term hypertrophy, which no chronic trial has separated

Why it sounds right. It follows from something real on this page: a body step, an animal result or a related finding.

The missing step. Nobody measured this in people for this use, or the study that did measure it did not show it.

What would change this

A study in people, for this exact use, measuring this exact thing, that a reviewer signs off.

RNAWiki has not yet published a reviewed conclusion for this use.

Goes past the evidence

That heavy metal contamination is a closed question because one industry-adjacent risk assessment computed a hazard index below 1

Why it sounds right. It follows from something real on this page: a body step, an animal result or a related finding.

The missing step. Nobody measured this in people for this use, or the study that did measure it did not show it.

What would change this

A study in people, for this exact use, measuring this exact thing, that a reviewer signs off.

RNAWiki has not yet published a reviewed conclusion for this use.

What is missing or unclearRead from sources, not yet reviewed

What nobody knows yet

Open questions, each with why it is open and what would close it.

How fast does the body clear it?

The sources RNAWiki checked hold nothing for this field.

Why it matters. Without this, nothing on this page can say how long anything lasts.

What would answer it

A stored source that records it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing populations

Which groups were under-represented in the studies has not been recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing long-term data

No completed tested study window is recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

No reviewed conclusion

RNAWiki has not yet published a reviewed conclusion for this use.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing interaction studies

No interaction was found in the registers checked. Not finding one is not the same as showing there is none.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Formulation uncertainty

Several salts, forms or products of Milk Basic Protein are recorded. Results from one form may not transfer to another.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Mechanism not reviewed

No reviewed mechanism story exists for this substance.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

What happened in peopleRead from sources, not yet reviewed

Check any of this yourself

Every line above traced back to the study it came from. This is the technical layer, and the vocabulary changes here.

Every line above can be traced to the study named beside it. Follow the link and read it.

The supplement effect is real, replicated, and 0.30 kg of fat-free mass
In plain words
Across 49 randomised trials in 1,863 people, adding protein to a training programme produced measurably more muscle and strength than training alone. The amount was about a third of a kilogram of lean mass.
What was measured
Change in fat-free mass, one-repetition maximum, muscle fibre cross-sectional area and mid-femur cross-sectional area
Effect estimate
No reviewed effect estimate exists for this record.
Limits
See the technical detail.
From the source
Morton and colleagues meta-analysed randomised controlled trials with at least six weeks of resistance training plus protein supplementation. Across 49 studies and 1,863 participants, protein supplementation significantly increased one-repetition-maximum strength by 2.49 kg (95% CI 0.64 to 4.33), fat-free mass by 0.30 kg (95% CI 0.09 to 0.52), muscle fibre cross-sectional area by 310 square micrometres (95% CI 51 to 570) and mid-femur cross-sectional area by 7.2 square millimetres (95% CI 0.20 to 14.30). Every one of those is statistically significant and every one is small. Two meta-regression findings matter as much as the headline: the effect on fat-free mass fell with increasing age (-0.01 kg per year, P = 0.002) and was larger in people already resistance-trained (+0.75 kg, P = 0.03). The population most often sold protein for sarcopenia is the population in which the supplement effect is weakest.
Source
Morton RW et al. Br J Sports Med 2018;52:376-384
Role in the trial
Not matched to a registered study
Identity check
no open identity hold
Audit mark
verified
Review state
Written into the record, not signed off as a reviewed claim
It stops working above 1.62 g per kg per day, and the analysis says so exactly
In plain words
The same meta-analysis found the point where extra protein stops adding anything: once total daily intake passes about 1.6 grams per kilogram of body weight, more protein produced no further muscle gain.
What was measured
Two-phase break point in the relationship between total protein intake and change in fat-free mass
Effect estimate
No reviewed effect estimate exists for this record.
Limits
See the technical detail.
From the source
A two-phase break point analysis across the 49 included studies determined that protein supplementation beyond a total protein intake of 1.62 g/kg/day resulted in no further resistance-training-induced gains in fat-free mass. This is not an opinion or a rule of thumb — it is a break point estimated from the pooled data, and it defines the exact boundary of the product's usefulness. A person already eating above that from food is, on the best available evidence, buying a supplement with a measured incremental effect of zero on fat-free mass, no matter how much of it they take. The finding also reframes the whole category: whey is not a muscle-building agent, it is a convenient way to reach a threshold, and past the threshold it is protein-flavoured food.
Source
Morton RW et al. Br J Sports Med 2018;52:376-384
Role in the trial
Not matched to a registered study
Identity check
no open identity hold
Audit mark
verified
Review state
Written into the record, not signed off as a reviewed claim
Whey does beat casein and soy acutely, by 122% and 31%
In plain words
A stable-isotope study measured muscle protein synthesis directly after equal amounts of essential amino acids from whey, casein or soy. Whey produced by far the biggest response.
What was measured
Fractional rate of mixed muscle protein synthesis, percent per hour, at rest and after resistance exercise
Effect estimate
No reviewed effect estimate exists for this record.
Limits
See the technical detail.
From the source
Tang and colleagues gave three groups of six healthy young men drinks matched for essential amino acid content at 10 g, as whey hydrolysate, micellar casein or soy protein isolate, after unilateral leg resistance exercise, with mixed muscle protein synthesis measured by primed constant infusion of L-[ring-13C6]phenylalanine. Whey produced larger increases in blood essential amino acids, branched-chain amino acids and leucine than either comparator (P < 0.05). At rest, mixed muscle protein synthesis was 0.091 +/- 0.015 %/h on whey, 0.078 +/- 0.014 on soy and 0.047 +/- 0.008 on casein — whey approximately 93% greater than casein (P < 0.01) and 18% greater than soy (P = 0.067). After exercise the ordering held: whey approximately 122% greater than casein (P < 0.01) and 31% greater than soy (P < 0.05). This is a genuine, mechanistically clean advantage for whey, and it is an acute synthesis rate in six men per group, not a training outcome. The chronic meta-analysis that measured training outcomes did not separate protein sources.
Source
Tang JE, Moore DR, Kujbida GW, Tarnopolsky MA, Phillips SM. J Appl Physiol 2009;107:987-992
Role in the trial
Not matched to a registered study
Identity check
no open identity hold
Audit mark
verified
Review state
Written into the record, not signed off as a reviewed claim
The anabolic window vanished when total protein was controlled for
In plain words
The belief that protein must be taken within an hour of training looked supported until researchers accounted for the fact that the timing groups also ate more protein overall. Then the effect disappeared.
What was measured
Effect size for muscle strength and hypertrophy attributable to protein timing, before and after covariate control
Effect estimate
No reviewed effect estimate exists for this record.
Limits
See the technical detail.
From the source
Schoenfeld, Aragon and Krieger ran a multi-level meta-regression of randomised controlled trials of protein timing. The strength analysis comprised 478 subjects and 96 effect sizes nested within 41 groups and 20 studies; the hypertrophy analysis comprised 525 subjects and 132 effect sizes nested within 47 groups and 23 studies. A simple pooled analysis without controlling for covariates showed a small-to-moderate effect of protein timing on hypertrophy and no significant effect on strength. In the full meta-regression model controlling for all covariates, no significant difference was found between treatment and control for either strength or hypertrophy, and the reduced model did not differ from the full model. Total protein intake was the strongest predictor of hypertrophy effect size. The authors wrote that these results refute the commonly held belief that timing of protein intake around a training session is critical. It is one of the cleanest published demonstrations that an apparently real effect was a confounder wearing a mechanism.
Source
Schoenfeld BJ, Aragon AA, Krieger JW. J Int Soc Sports Nutr 2013;10:53
Role in the trial
Not matched to a registered study
Identity check
no open identity hold
Audit mark
verified
Review state
Written into the record, not signed off as a reviewed claim
Twenty grams maxed out the response, and the surplus was oxidised
In plain words
A dose-response study found muscle protein synthesis peaked at 20 grams of protein after training. Forty grams did not build more; it was burned for energy instead.
What was measured
Muscle and albumin protein synthesis and whole-body leucine oxidation across 0, 5, 10, 20 and 40 g protein doses
Effect estimate
No reviewed effect estimate exists for this record.
Limits
See the technical detail.
From the source
Moore and colleagues had six healthy young men perform intense leg resistance exercise on five separate occasions and consume, in randomised order, drinks containing 0, 5, 10, 20 or 40 g of whole egg protein, with protein synthesis and whole-body leucine oxidation measured over four hours by primed constant infusion of [1-13C]leucine. Muscle protein synthesis showed a dose response and was maximally stimulated at 20 g. Albumin synthesis also plateaued at 20 g. Leucine oxidation increased significantly after 20 and 40 g — that is, protein consumed above the threshold was demonstrably burned rather than incorporated. Phosphorylation of p70S6K, ribosomal protein S6 and eIF2B-epsilon was unaffected by any dose, which the authors read as evidence that the stimulation depends on amino acid availability rather than on further signalling amplification. Six men and whole egg protein is a narrow base, and larger doses matter more in older adults and after whole-body training. But the shape of the curve — a plateau with oxidation of the excess — is the single most useful fact about protein dosing and the one the 50-gram serving scoop ignores.
Source
Moore DR et al. Am J Clin Nutr 2009;89:161-168
Role in the trial
Not matched to a registered study
Identity check
no open identity hold
Audit mark
caution
Review state
Written into the record, not signed off as a reviewed claim
The kidney warning did not survive the meta-analysis
In plain words
High-protein diets were long said to damage kidneys. Pooling 28 randomised trials in healthy adults found no difference in the change in kidney filtration rate.
What was measured
Glomerular filtration rate, post-intervention and as change from baseline, on higher versus normal or lower protein intakes
Effect estimate
No reviewed effect estimate exists for this record.
Limits
See the technical detail.
From the source
Devries and colleagues systematically reviewed randomised controlled trials longer than four days comparing higher-protein intakes (at least 1.5 g/kg body weight, or at least 20% of energy, or at least 100 g/day) against normal or lower protein intakes, in adults without kidney disease, with glomerular filtration rate as the outcome. Twenty-eight trials with 1,358 participants were analysed. The post-intervention comparison showed a trivial effect for GFR to be higher after higher-protein intakes (standardised mean difference 0.19, 95% CI 0.07 to 0.31, P = 0.002), while the change in GFR from pre- to post-intervention did not differ between interventions (SMD 0.11, 95% CI -0.05 to 0.27, P = 0.16). There was a linear relation between protein intake and post-intervention GFR (r = 0.332, P = 0.03) but not between protein intake and the change in GFR (r = 0.184, P = 0.33). The physiological reading is that a higher protein load raises filtration as an adaptive response, not as an injury. The caveat that belongs on the record: these are healthy adults, and the trials are short relative to a lifetime of habitual intake.
Source
Devries MC et al. J Nutr 2018;148:1760-1775
Role in the trial
Not matched to a registered study
Identity check
no open identity hold
Audit mark
verified
Review state
Written into the record, not signed off as a reviewed claim
Heavy metals: found repeatedly, then assessed as safe by industry-adjacent consultants
In plain words
Consumer testing found arsenic, cadmium, mercury and lead in protein powders, with 40 percent of 133 products elevated. A follow-up risk assessment concluded the exposures were below regulatory thresholds. Its three authors all worked for the same litigation-support consultancy.
What was measured
That a hazard index below the regulatory screening threshold, calculated by industry-adjacent consultants, closes the question of heavy metal contamination in protein powders
Effect estimate
No reviewed effect estimate exists for this record.
Limits
See the technical detail.
From the source
Bandara, Towle and Monnot performed a human health risk assessment responding to a Consumer Reports analysis of 15 protein powders, which had found that average heavy metal amounts in three servings per day exceeded the maximum limits proposed by the US Pharmacopeia, and to a follow-up study reporting that 40% of 133 protein powder products tested had elevated heavy metal levels. Using US EPA reference doses for arsenic and cadmium, the EPA screening level for mercury, and the EPA Adult Lead Methodology model, they calculated hazard quotients and a cumulative hazard index for each product at one and three servings per day. All hazard indices were below 1 and all modelled blood lead levels were below the CDC guidance value of 5 micrograms per decilitre. The highest hazard indices, approaching 1, were in mass-gain products; the lowest were in whey protein powders. Their conclusion was that typical intake would not result in adverse health effects. Two facts belong alongside that conclusion. First, all three authors were affiliated with Cardno ChemRisk, a consultancy whose work is frequently commissioned in product-liability contexts. Second, "hazard index below 1" is a regulatory screening threshold, not a demonstration of no effect, and the underlying contamination finding — that the metals are present, and elevated in a substantial minority of products — is not in dispute.
Source
Bandara SB, Towle KM, Monnot AD. Toxicol Rep 2020;7:1255-1262
Role in the trial
Not matched to a registered study
Identity check
no open identity hold
Audit mark
contested
Review state
Written into the record, not signed off as a reviewed claim

Where else this substance is registered

FDA substance identifier (UNII)
8617Z5FMF6
CAS registry number
91082-88-1
EMA substance identifier
100000124334
European Chemicals Agency number
293-803-2

Checks this page had to pass

  • Passed

    Identity resolved

    no open identity hold

  • Passed

    No unresolved merge across substance families

    no quarantine open

  • Passed

    Every public sentence names a source

    The opening statement carries the origin: Written into the record, not signed off.

  • Not passed

    Trial roles classified for highlighted evidence

    No registered study is classified as testing this substance.

  • Passed

    No internal keys in reader text

    enforced by the copy-contract test over the rendered page

  • Passed

    Safety mode resolved

    The identity record classes it as a supplement ingredient; no medicines register records an approval.

  • Passed

    Canonical metadata present

    slug and display name present

What is missing or unclearRead from sources, not yet reviewed

What to learn next

Ordered by what would most change how you read this page, starting with what is easiest to misunderstand.

This order is fixed in code and does not count clicks or time on the page.

What is not here

5 questions this page could not answer

These sections were prepared and left out because there was nothing to put in them. They are listed rather than hidden, so the gaps in this record are visible.

  • How long anything takes — found nothing in the sources checked.
  • What it may clash with — found nothing in the sources checked.
  • Other ways to the same goal — found nothing in the sources checked.
  • How this medicine reached us — found nothing in the sources checked.
  • What changed on this page — found nothing in the sources checked.

The record as stored

The full record, for auditing

Everything above is built from what is below. This layer keeps the technical vocabulary, record identifiers and every stored row, so a reader who wants to check the page can.

The older medicine-wide conclusion held in this record

Written for a clinical reader, and about the medicine as a whole rather than about one indication, population and set of trials. RNAWiki does not treat it as a programme conclusion and no reviewer has signed it off in that form. It is here word for word because it is what the record holds.

Across 49 trials in 1,863 people, protein supplementation added 0.30 kg of fat-free mass and 2.49 kg of one-repetition maximum on top of resistance training — a real, replicated, modest effect that stops entirely once total protein intake passes 1.62 g/kg/day, and the post-workout anabolic window disappeared once total daily intake was controlled for.

Recorded evidence blocks (11)

What did Milk Basic Protein's largest trial (293 people) and its longest (7.3 years) measure?


293 people in Milk Basic Protein's largest registered study, 7.3 years in its longest registered window, measuring Frailty. ClinicalTrials.gov · 2026-09-01

115 na, 4 phase1, 2 phase2, 2 phase3, 2 phase4, 1 na or unstated; NCT01587911; 2015-09. Last human test completed 2026, NCT07571720.

Interpretation These counts include studies where Milk Basic Protein was a comparison treatment, a background treatment or an exposure in an observational study, and the longest window may be a planned end date. Trial roles have not yet been classified for this record.

Show the evidence
  • na
    115
  • phase1
    4
  • phase2
    2
  • phase3
    2
  • phase4
    2
  • na or unstated
    1
1 more recorded row
  • Last recorded human test NCT07571720
    2026-03-30

recorded 2026-09-01 · last checked 2026-09-04

Milk Basic Protein was tested only in human — what did it show?


human: healthspan (125): the rungs where Milk Basic Protein has a recorded finding. Europe PMC and ClinicalTrials.gov · organism ladder · 2026-09-01

Interpretation Frailty — the recorded outcome words.

Yeast C. elegans Drosophila Mouse Rat Dog Non-human primate Human healthspan
Show the evidence
  • human NCT07029243
    healthspan; Frailty; 125

recorded 2026-09-01 · last checked 2026-09-04

3 of Milk Basic Protein's trials stopped: safety, other?


safety (1) and other (2): Milk Basic Protein's stop wording, clustered. ClinicalTrials.gov · 2026-09-01

"Terminated for futility on 11/30/09 based on the recommendation of the DSMB"; 3 of 125 registered studies

Show the evidence

Trial

  • NCT00395161
    terminated; "Terminated for futility on 11/30/09 based on the recommendation of the DSMB"
  • NCT03065348
    terminated; "lack of study participants"
  • NCT04812704
    terminated; "inclusion difficulty"

recorded 2026-09-01 · last checked 2026-09-04

Human studies of Milk Basic Protein used 20 g whey protein — over how long?


Human studies of Milk Basic Protein used "20 g whey protein". ClinicalTrials.gov · 2026-09-01

5 recorded entries; human; also "14 g Whey protein", "Whey Protein-20g", "Whey protein (20 grams)"

Show the evidence

human

  • NCT02343471
    20 g whey protein
  • NCT02918981
    14 g Whey protein
  • NCT03595436
    Whey Protein-20g
  • NCT06858449
    Whey protein (20 grams)
  • NCT07704476
    Whey protein (60 grams)

recorded 2026-09-01 · last checked 2026-09-04

Could one person measure Milk Basic Protein's effect on systolic and diastolic blood pressure?


Systolic and diastolic blood pressure: measured in Milk Basic Protein's trials.

Interpretation systolic and diastolic blood pressure is the recorded endpoint.

Show the evidence

biomarkers

  • systolic and diastolic blood pressure; 2026-09-01
  • triglyceride levels; 2026-09-01
  • net whole body protein balance; 2026-09-01
  • net whole body protein synthesis; 2026-09-01
  • postprandial triglyceride response; 2026-09-01
  • muscle protein synthesis; 2026-09-01
14 more recorded rows
  • biomarkers
    body composition; 2026-09-01
  • biomarkers
    strength; 2026-09-01
  • biomarkers
    post prandial satiety; 2026-09-01
  • biomarkers
    plasma glucose; 2026-09-01
  • biomarkers
    six minute walk test; 2026-09-01
  • biomarkers
    muscle mass; 2026-09-01
  • biomarkers
    metabolism; 2026-09-01
  • biomarkers
    lean mass; 2026-09-01
  • biomarkers
    muscle function; 2026-09-01
  • biomarkers
    4 meter gait speed; 2026-09-01
  • biomarkers
    walk distance; 2026-09-01
  • biomarkers
    lean body mass /fat mass; 2026-09-01
  • biomarkers
    blood glucose level; 2026-09-01
  • biomarkers
    body mass index; 2026-09-01
  • human trials at or under30
    58
  • Not recorded for this substance
    a recorded half-life
  • smallest human trial
    2; NCT04812704; NA; the smallest recorded human enrolment at or below 30; the registry states no direction of its result; TERMINATED

Which of 4 meter gait speed, blood glucose level and body composition did Milk Basic Protein's trials measure?


4 meter gait speed, blood glucose level and body composition lead 40 outcome terms across Milk Basic Protein's trials. ClinicalTrials.gov · 2026-09-01

Interpretation net whole body protein synthesis, postprandial triglyceride response, muscle protein synthesis, body composition, strength and post prandial satiety follow.

Show the evidence
  • systolic and diastolic blood pressure
    1
  • triglyceride levels
    1
  • net whole body protein balance
    1
  • net whole body protein synthesis
    1
  • postprandial triglyceride response
    1
  • muscle protein synthesis
    1
14 more recorded rows
  • body composition
    1
  • strength
    1
  • post prandial satiety
    1
  • plasma glucose
    1
  • six minute walk test
    1
  • muscle mass
    1
  • metabolism
    1
  • lean mass
    1
  • muscle function
    1
  • 4 meter gait speed
    1
  • walk distance
    1
  • lean body mass /fat mass
    1
  • blood glucose level
    1
  • body mass index
    1

recorded 2026-09-01 · last checked 2026-09-04

Which of Milk Basic Protein's 19 ongoing trials reports first?


19 registered trials of Milk Basic Protein are open; earliest completion 2025-04-01. ClinicalTrials.gov · 2026-09-01

Glycaemic response; Osteocalcin; latest 2029-07

Show the evidence

Trial

  • NCT04869098
    "Effects of an Evening PROtein PrEload on Metabolic Health in Night ShIfT Workers (PROPENSITy)"; n 30; "Glycaemic response"; 2026-07-31
  • NCT05922462
    "Effects of Increased Greek Yogurt Consumption in Youth and Young Adult Athletes"; n 40; "Osteocalcin"; 2026-04-30
  • NCT06606717
    "Effects of Resistance-band Training and Creatine and Whey Protein"; n 36; "Whole-body lean mass (kg)"; 2025-07
  • NCT06682715
    "Impact of Nutrition Education and Whey Supplementation on Body Composition and Endurance Performance of Athletes"; n 20; "Change in body composition parameters (% fat mass, % fat-free mass, BMI) measured by InBody-270 analyzer over 5 weeks"; 2025-04-01
  • NCT06825377
    "Comparing High-protein Vs. Standard Protein Nutritional Support in Critically Ill Patients At Risk for Refeeding Syndrome"; n 150; "Number of participants with refeeding syndrome"; 2026-04-15
  • NCT06858449
    "Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer"; n 30; "Changes in muscle mass and fat mass (pounds) at completion of chemotherapy"; 2027-03
13 further recorded trials
  • NCT06874400
    "Comparison of Dairy and Plant-based Alternatives in Adolescents and Older Adults"; n 160; "Blood glucose"; 2028-04-01
  • NCT06955975
    "The Effect of Pectin Supplementation on Geriatric With Frailty: A Randomised Placebo-Controlled Dietary Intervention Study"; n 30; "Change in microbiome profile"; 2026-03-31
  • NCT07029243
    "Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis"; n 100; "Frailty"; 2026-12
  • NCT07159919
    "Insect vs Animal Protein for Building Muscle"; n 34; "Anabolic signalling"; 2027-01
  • NCT07167277
    "The Impact of Whey Protein on Frailty in Older Adults Classified as Pre-frail"; n 20; "Change in brain glutathione (GSH) levels measured using MRI scans."; 2026-09
  • NCT07299110
    "Effect of Whey Protein Versus Egg Albumen Protein Challenge on Blood Ammonia Level in Patients of Decompensated Ethanol Related Cirrhosis."; n 50; "To compare the effects of whey protein versus egg albumen protein oral challenge in blood ammonia level after 3 hours in decompensated ethanol related cirrhosis."; 2025-12-31
  • NCT07451496
    "PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS)"; n 20; "Change from baseline in cardiorespiratory fitness (VO₂peak)"; 2026-06-30
  • NCT07487623
    "Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study)."; n 26; "Liver function measurements"; 2026-05-15
  • NCT07528469
    "The Effects of PeptiStrong and Whey on Muscle Function In Older Adults"; n 80; "Hand Grip Strength via hand held dynamometer"; 2026-10-30
  • NCT07561619
    "Yeast Protein for Muscle Mass"; n 72; "Changes in muscle mass"; 2029-07
  • NCT07594444
    "Whey Protein and Adaptogenic Supplementation in Physically Active Females"; n 60; "Salivary Cortisol Concentration"; 2026-09-20
  • NCT07704476
    "EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer"; n 40; "Determine changes in pounds of muscle and fat mass after each exercise regimen"; 2027-06
  • NCT07716904
    "Whey Protein and Adaptogenic Supplementation in Physically Active Males"; n 60; "Salivary Cortisol Concentration"; 2026-10-01

recorded 2026-09-01 · last checked 2026-09-04

Which running trial of Milk Basic Protein could settle vo2max?


NCT07451496 measures Change from baseline in cardiorespiratory fitness (VO₂peak), reading out 2026-06-30.

3 open trials; n 20; "PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS)"

Show the evidence

Trial

  • NCT07451496
    "PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS)"; n 20; "Change from baseline in cardiorespiratory fitness (VO₂peak)"; 2026-06-30
  • NCT07528469
    "The Effects of PeptiStrong and Whey on Muscle Function In Older Adults"; n 80; "Hand Grip Strength via hand held dynamometer"; 2026-10-30
  • NCT07029243
    "Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis"; n 100; "Frailty"; 2026-12

Which 76 trials of Milk Basic Protein posted no result?


Posted no result
76 of 76 completed trials
Registrations
NCT01418469, NCT00838149, NCT00659672, NCT01074879, NCT01492010 and NCT01154400, and 70 more
Completion dates
oldest 2004-12; newest 2024-06-28
Show the evidence

Trial

  • NCT01418469
    2004-12
  • NCT00838149
    2008-11
  • NCT00659672
    2009-02
  • NCT01074879
    2009-12
  • NCT01492010
    2010-09
  • NCT01154400
    2011-07
14 further recorded trials
  • NCT01960335
    2012-09
  • NCT01830946
    2012-11
  • NCT01298817
    2012-12
  • NCT01472666
    2012-12
  • NCT01662414
    2012-12
  • NCT01792297
    2013-02
  • NCT01957423
    2013-03
  • NCT01530646
    2013-05
  • NCT02413671
    2013-07
  • NCT01727570
    2013-10
  • NCT01580189
    2013-12
  • NCT01749189
    2014-06
  • NCT02087124
    2014-06
  • NCT02315014
    2014-06

At the median, Milk Basic Protein's trials enrolled 34 people — anything larger?


Median enrolment
34
Largest enrolment
293
Registered trials counted
125

Was Milk Basic Protein studied with exercise?


exercise is named in Milk Basic Protein's label sentences: "A 1-year randomized controlled trial examined effects of milk basic protein (MBP) supplementation (40 mg day⁻¹) and daily physical activity (step count and duration of exercise > 3 metabolic equivalents [METs]) on bone metabolism, forearm bone mineral density (BMD) and a calcaneal osteosonic index…" openfda-label+europepmc · 2010-10-01

1 recorded statement; exercise

Show the evidence
  • exercise
    A 1-year randomized controlled trial examined effects of milk basic protein (MBP) supplementation (40 mg day⁻¹) and daily physical activity (step count and duration of exercise > 3 metabolic equivalents [METs]) on bone metabolism, forearm bone mineral density (BMD) and a calcaneal osteosonic index (OSI) in 79 females aged 65-86 years.

recorded 2010-10-01 · last checked 2026-09-04

Where it is registered
Identifiers, relations and other names

The exact record

CAS number
91082-88-1
Also called
Whey, Whey protein, ALLERGENIC EXTRACT- WHEY, COW'S MILK, BOVINE MILK PLASMA, BOVINE WHEY, COW MILK WHEY, FOOD - DAIRY PRODUCTS, WHEY, COW'S MILK, PROTEINS, WHEY, ULTRACUR COMPONENT WHEY PROTEIN, WHEY PROTEIN CONCENTRATE, WHEY PROTEIN CONCENTRATE [VANDF]
Trade name
Dairy Antigens, Psora Miasm, Joint and Tendon Rescue, Dairy Mix 1004, Dairy Antigens / Psora Miasm / Joint and Tendon Rescue / Dairy Mix 1004, Sold as whey concentrate, whey isolate and whey hydrolysate — three processing grades of the same starting material
Sources (6)

Sources

ClinicalTrials.gov — US Government work · Europe PMC — metadata only, under the recorded legal gate · derived from this page's own recorded fields; no external licence · mixed register set; per-register licences in docs/specs/corpus-20k-sources.md · openFDA / DailyMed — US Government work

How these records are assembled · Which registers were checked

Index-quality checks
  • identity passed: no open identity hold
  • required summary fields resolved: 4 required field(s) not terminal: Why people use it, Best-supported result, Biggest unanswered question, Human evidence
  • public claims reviewed: 0 reviewed claim(s); drafts are never rendered
  • source coverage passed: 6 source rows
  • no critical contamination: no quarantine open
  • canonical metadata passed: slug and display name present
  • no raw internal fields: enforced by the copy-contract test over the rendered page

This is a record of evidence. It is not medical advice, and it does not say this substance suits you. Nothing here says any substance on RNAWiki is appropriate for a child.